ArticleClinical case reports2025
Biphasic Synovial Sarcoma of the Palatine Tonsil: A Case Report and Literature Review.
Article in Clinical case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Biphasic Synovial Sarcoma of the Palatine Tonsil: A Case Report and Literature Review.Clinical case reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Synovial sarcoma (SS) is a rare soft tissue tumor, accounting for 5%-10% of all soft tissue sarcomas, with an unusual occurrence in the head and neck region. This report presents a 29-year-old male with a biphasic SS of the left palatine tonsil, manifesting as progressive dysphagia, odynophagia, hoarseness, and left cervical lymphadenopathy. Clinical examination and imaging revealed a 4 × 4 mass arising from the left tonsil and obstructing the oropharyngeal inlet. Left tonsillectomy was done and the histopathological evaluation revealed a biphasic SS and negative margins. The diagnosis was further supported by a positive transducin-like enhancer of split-1 (TLE-1), SS translocation on chromosome 18 (SS18), and epithelial membrane antigen (EMA). The patient underwent chemotherapy and external beam radiotherapy (60 Gy in 30 fractions), with significant clinical improvement. This case highlighted the importance of a multidisciplinary approach in diagnosing and managing a rare head and neck SS. Furthermore, this is the first reported case from Pakistan, emphasizing the need for awareness in atypical locations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.